While we are focused on developing the best possible cannabinoid products, we believe that improving the health and wellbeing of patients goes beyond this. That’s why we are committed to investing in research and development.
In addition to continuing to invest in research and development in-house, we understand that a strong partnership with clinicians and researchers is key to expanding the industry and helping people.
By prioritising research, we have the power to discover the full potential of cannabinoid medicines in treating diseases and improving lives. That’s why we partner with key universities to undertake cannabis research and support their clinical trial programs.
The aim of this survey-based study was to assess the effects of medicinal cannabis on severe nausea and vomiting during pregnancy. The results based on interviews with 84 female patients show that medicinal cannabis can help treat the condition however the study also supports the need for further investigations.
The aim of the survey completed by 640 Australian general practitioners (GP) was to examine the knowledge and attitudes of GP towards medicinal cannabis. The results show that the majority of surveyed practitioners are supportive or neutral when it comes to medicinal cannabis use.
We currently have a research partnership with the Hunter Medical Research Institute, a partner of the University of Newcastle. For more information about how to become a partner please contact us.